A Phase II, double-blind, parallel-group comparison study of S-556971 in patients with dyslipidemia
Latest Information Update: 10 Jun 2016
Price :
$35 *
At a glance
- Drugs KT6 971 (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 02 Oct 2012 New trial record